AVADEL PHARMACEUTICALS PLC Insider Trading Activity
Every SEC Form 4 insider transaction reported for AVADEL PHARMACEUTICALS PLC (AVDL), sourced directly from SEC EDGAR and updated as new filings are accepted.
By Trabud · Insider-trading data from SEC EDGAR
Latest filing:
Compiled automatically from SEC EDGAR Form 4 filings and refreshed daily. Figures count purchases (code P) and sales (code S) only — not grants, option exercises, or gifts. How this page is built. Not investment advice.
Quick Answer
Are AVDL insiders buying or selling?
In the last 12 months, AVADEL PHARMACEUTICALS PLC insiders reported 0 open-market purchases ($0) and 1 sale ($233.4M) — net selling of $233.4M. Since May 2018, Trabud has recorded 54 Form 4 filings for AVDL: 45 buys ($4.4M) and 9 sells ($235.7M).
Source: SEC EDGAR Form 4
What stands out
- No AVADEL PHARMACEUTICALS PLC insider made an open-market purchase in the last 12 months; the 1 reported open-market sale totaled $233.4M.
Key Statistics (May 2018 – Feb 18, 2026)
Total Form 4 filings
54
SEC EDGAR
Insider filers
13
Insider buys (45)
$4.4M
Insider sells (9)
$235.7M
Insider sentiment
Net sellingNet insider flow of $231.3M in net selling since May 2018, and $233.4M in net selling over the last 12 months.
Recent AVDL insider transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Feb 18, 2026 | Weiss Asset Management LP | Other | Sale | 11.1M | $21.00 | $233.4M | SEC ↗ |
| Jan 22, 2025 | Linda Palczuk | Director | Purchase | 5.0K | $7.93 | $39.6K | SEC ↗ |
| Jan 14, 2025 | Peter J. Thornton | Director | Purchase | 10.0K | $8.05 | $80.5K | SEC ↗ |
| Jan 14, 2025 | Eric J Ende | Director | Purchase | 30.0K | $7.84 | $235.2K | SEC ↗ |
| Dec 16, 2024 | Thomas S Mchugh | Chief Financial Officer | Purchase | 2.3K | $10.44 | $24.0K | SEC ↗ |
| Dec 12, 2024 | Thomas S Mchugh | Chief Financial Officer | Purchase | 5.0K | $10.49 | $52.4K | SEC ↗ |
| Dec 10, 2024 | Gregory J Divis | Chief Executive Officer | Purchase | 10.0K | $9.97 | $99.7K | SEC ↗ |
| Dec 10, 2024 | Geoffrey Michael Glass | Director | Purchase | 20.3K | $9.84 | $199.6K | SEC ↗ |
| Dec 10, 2024 | Linda Palczuk | Director | Purchase | 3.0K | $10.19 | $30.6K | SEC ↗ |
| Jan 16, 2024 | Thomas S Mchugh | Chief Financial Officer | Purchase | 2.0K | $14.50 | $29.0K | SEC ↗ |
| Dec 29, 2023 | Mark Anthony Mccamish | Director | Sale | 75.0K | $14.53 | $1.1M | SEC ↗ |
| Aug 15, 2023 | Mark Anthony Mccamish | Director | Sale | 29.0K | $14.93 | $432.6K | SEC ↗ |
| Aug 14, 2023 | Thomas S Mchugh | Chief Financial Officer | Purchase | 2.0K | $14.45 | $28.9K | SEC ↗ |
| Aug 11, 2023 | Geoffrey Michael Glass | Director | Purchase | 14.0K | $13.40 | $187.6K | SEC ↗ |
| Aug 10, 2023 | Gregory J Divis | Chief Executive Officer | Purchase | 10.0K | $13.20 | $132.0K | SEC ↗ |
| May 19, 2023 | Eric J Ende | Director | Purchase | 13.0K | $13.93 | $181.1K | SEC ↗ |
| May 10, 2023 | Linda Palczuk | Director | Purchase | 2.5K | $14.76 | $36.9K | SEC ↗ |
| Dec 28, 2022 | Linda Palczuk | Director | Purchase | 2.0K | $7.20 | $14.4K | SEC ↗ |
| Nov 30, 2022 | Thomas S Mchugh | Chief Financial Officer | Purchase | 5.0K | $7.80 | $39.0K | SEC ↗ |
| Nov 23, 2022 | Eric J Ende | Director | Purchase | 20.0K | $7.80 | $156.1K | SEC ↗ |
| Jun 3, 2022 | Geoffrey Michael Glass | Director | Purchase | 45.0K | $2.14 | $96.3K | SEC ↗ |
| Jun 2, 2022 | Geoffrey Michael Glass | Director | Purchase | 45.0K | $2.14 | $96.3K | SEC ↗ |
| Jun 1, 2022 | Eric J Ende | Director | Purchase | 35.0K | $2.23 | $77.9K | SEC ↗ |
| May 31, 2022 | Linda Palczuk | Director | Purchase | 10.0K | $1.60 | $16.0K | SEC ↗ |
| May 31, 2022 | Thomas S Mchugh | Chief Financial Officer | Purchase | 50.0K | $2.14 | $106.9K | SEC ↗ |
Showing the 25 most recent of 54 Form 4 filings for AVADEL PHARMACEUTICALS PLC.
Most active AVDL insiders
- Eric J Ende10 filings
- Thomas S Mchugh9 filings
- Geoffrey Michael Glass7 filings
- Linda Palczuk7 filings
- Gregory J Divis6 filings
Ask anything about AVDL insider activity
Use Trabud's AI agent to query AVADEL PHARMACEUTICALS PLC's Form 4 history in plain English — "Show me AVDL CEO purchases this year" or compare it against any other ticker.
Open the AI agentAVDL insider trading FAQ
Are AVADEL PHARMACEUTICALS PLC insiders buying or selling?
In the last 12 months, AVADEL PHARMACEUTICALS PLC insiders reported 0 open-market purchases ($0) and 1 sale ($233.4M) — net selling of $233.4M. Since May 2018, Trabud has recorded 54 Form 4 filings for AVDL: 45 buys ($4.4M) and 9 sells ($235.7M). Over the full record that is net selling of $231.3M.
How many insiders trade AVDL stock?
13 distinct insider filers — officers, directors, 10%+ owners, and investment groups filing jointly — have reported Form 4 transactions for AVADEL PHARMACEUTICALS PLC. The most recent filing was accepted on Feb 18, 2026.
Where does Trabud get AVDL insider trading data?
All AVDL insider trading data comes directly from official SEC EDGAR Form 4 filings, which corporate insiders must submit within two business days of a transaction under Section 16(a) of the Securities Exchange Act of 1934.